Literature DB >> 32955211

Environmental risk factors and epigenetic alternations in psoriasis.

Marek Roszkiewicz1, Klaudia Dopytalska1, Elżbieta Szymańska1, Artur Jakimiuk2, Irena Walecka1.   

Abstract

INTRODUCTION AND
OBJECTIVE: Psoriasis isa quite common, chronic and immune-mediated skin disorder. The prevalence of psoriasis differs in various countries, but it is said to affect 2% of the world's population in general. Psoriasis has many different clinical features but all lesions have the same characteristic: erythema, thickening and scale, although other clinical features are also connected, such as psoriatic arthritis, obesity and metabolic syndrome. All of these may lead to conditions impairing the quality of life. This review is an attempt to summarize recent data regarding environmental factors, together with epigenetic markers and processes playing an important role in psoriasis. STATE OF KNOWLEDGE: Many different environmental factors play a role in genetically predisposed patients. This is causes epigenetic alternations which may be a linking part in the whole process. Many studies have indicated a connection between psoriasis and various genes and antigens. The presence of HLA-Cw6 is common as well a strong link between its presence and the onset of psoriasis being observed. The main alternations are DNA methylation, histone's modifications and the role of microRNA. Excessive reaction is usually not present without a triggering factor. Environmental factors are mostly rated, such as drugs, life style and habits (smoking, alcohol), diet, physical trauma (skin injury provoking Koebner phenomenon), stress, microorganism and infections.
CONCLUSIONS: The correlation between pathogenesis of psoriasis and environmental risk factors, together with epigenetic alternations still require more investigation. Education about diet habits, nutrition, weight loss and healthy lifestyle seems to be important during the treatment of psoriasis.

Entities:  

Keywords:  environmental factors; epigenetic alternations; habits; psoriasis

Mesh:

Year:  2019        PMID: 32955211     DOI: 10.26444/aaem/112107

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  11 in total

Review 1.  Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review.

Authors:  Chanel Claudine de Ruiter; Thomas Rustemeyer
Journal:  Psoriasis (Auckl)       Date:  2022-05-24

Review 2.  Psoriasis and Gut Microbiome-Current State of Art.

Authors:  Karina Polak; Beata Bergler-Czop; Michał Szczepanek; Kamila Wojciechowska; Aleksandra Frątczak; Norbert Kiss
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

3.  Moxibustion therapy for treating psoriasis vulgaris: A protocol for systematic review and meta-analysis.

Authors:  Jiahua Zou; Gang Huang; Chuxiang Hu; Juan Yan; Feiyan Zhang; Haiyong Shi; Xian Yuan; Jiajun Fu; Liping Gong
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

Review 4.  The Molecular Pathophysiology of Psoriatic Arthritis-The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome.

Authors:  Ana L Carvalho; Christian M Hedrich
Journal:  Front Mol Biosci       Date:  2021-04-01

5.  Alpha-7 nicotinic acetylcholine receptor agonist alleviates psoriasis-like inflammation through inhibition of the STAT3 and NF-κB signaling pathway.

Authors:  Yiwen Chen; Panpan Lian; Ziqi Peng; Junaid Wazir; Chujun Ma; Lulu Wei; Li Li; Jun Liu; Chen Zhao; Wenyuan Pu; Hongwei Wang; Zhonglan Su
Journal:  Cell Death Discov       Date:  2022-03-30

Review 6.  Contribution of the Environment, Epigenetic Mechanisms and Non-Coding RNAs in Psoriasis.

Authors:  Charalabos Antonatos; Katerina Grafanaki; Paschalia Asmenoudi; Panagiotis Xiropotamos; Paraskevi Nani; Georgios K Georgakilas; Sophia Georgiou; Yiannis Vasilopoulos
Journal:  Biomedicines       Date:  2022-08-09

Review 7.  The role of leptin in selected skin diseases.

Authors:  Klaudia Dopytalska; Agnieszka Baranowska-Bik; Marek Roszkiewicz; Wojciech Bik; Irena Walecka
Journal:  Lipids Health Dis       Date:  2020-10-02       Impact factor: 3.876

8.  An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis.

Authors:  Magdalena Kutwin; Monika Migdalska-Sęk; Ewa Brzeziańska-Lasota; Piotr Zelga; Anna Woźniacka
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

Review 9.  Interleukin-1 Links Autoimmune and Autoinflammatory Pathophysiology in Mixed-Pattern Psoriasis.

Authors:  Rodolfo Kölliker Frers; Matilde Otero-Losada; Tamara Kobiec; María Inés Herrera; Lucas Udovin; Carlos F Kusnier; Francisco Capani
Journal:  Mediators Inflamm       Date:  2021-10-16       Impact factor: 4.711

Review 10.  Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease.

Authors:  Yuichi Yamamoto; Norihiro Kanayama; Yusuke Nakayama; Nobuko Matsushima
Journal:  J Pers Med       Date:  2022-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.